The contribution of patient involvement to policy Medicines R&D In this video, three patient advocates discuss the contribution of patient involvement to healthcare policy. Read more »
What is meaningful patient involvement in HTA? Medicines R&D In this video, three patient advocates discuss what meaningful patient involvement in HTA looks like. Read more »
Best practices for patient involvement in HTA processes Medicines R&D In this video, three patient advocates discuss best practices in patient involvement in HTA. Read more »
Overcoming obstacles to patient involvement in HTA Medicines R&D In this video, patient advocates discuss how to overcome barriers to patient involvement in HTA. Read more »
How can regulators strengthen the patient voice in HTA? Medicines R&D In this video, patient advocates discuss how regulators can strengthen the patient voice in HTA. Read more »
Necessary training for patients involved in HTA Medicines R&D In this video, patient advocates discuss necessary training for patients involved in HTA processes. Read more »
Patient organisation involvement in HTA processes Medicines R&D In this video, three patient advocates discuss patient organisation involvement in HTA processes. Read more »
HTA systems in Europe Medicines R&D HTA systems in Europe differ, but usually involve assessment and appraisal steps. Read more »
Ethical, social, and legal issues (ELSI) in HTA Medicines R&D HTA bodies must take into account ethical, legal, and social issues (ELSI) during their assessments of health technologies. Read more »
Patient-reported outcomes (PROs) assessment Medicines R&D Patient-reported outcomes (PROs) focus on real benefits important to and achievable for patients. Read more »
